Mandate

Vinge advises Adelis in connection with the acquisition of Logent

November 12, 2013

Vinge is advising Adelis Equity Partners Fund 1 AB in connection with its acquisition of Logent AB (“Logent”) from the company’s two founders and Inter IKEA Investments AB. The acquisition is taking place together with the company’s management. It is anticipated that the transaction will be completed by the end of November 2013. Logent was founded in 2006 and has had growth in sales over the last five years of more than 60% per year, both organically and as a result of strategic acquisitions. Logent currently has an extensive network of on-site solutions in Sweden and Norway and has approximately 3500 employees. Logent’s turnover for 2013 is expected to amount to approximately SEK 1.3 billion.

Vinge’s team consists of responsible partner Christina Kokko together with Johan Mattsson and Gustav Jönsson. Partner Mikael Ståhl and associates Sofia Graflund and Emelie Klefbeck advised on acquisition financing issues. Partners Mattias Scömer, Odile Fallenius and Johan Larsson and associates Ulf Nilsson and Emelie Parland advised Adelis in relation to funds, tax, and VAT issues.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025